ZIRCONIUM-89 OXINE COMPLEX AS A CELL LABELING AGENT FOR POSITRON EMISSION TOMOGRAPHY Read more about ZIRCONIUM-89 OXINE COMPLEX AS A CELL LABELING AGENT FOR POSITRON EMISSION TOMOGRAPHY US Patent 11,192,903Filed on 2019-12-20
Pharmaceutical Compositions Of Fenretinide Having Increased Bioavailability And Methods Of Using Them Read more about Pharmaceutical Compositions Of Fenretinide Having Increased Bioavailability And Methods Of Using Them Japan2009-184500Filed on 2009-08-07
Pharmaceutical Compositions Of Fenretinide Having Increased Bioavailability And Methods Of Using Them Read more about Pharmaceutical Compositions Of Fenretinide Having Increased Bioavailability And Methods Of Using Them Japan2002-559023Filed on 2001-12-05
COMBINATION PDL1 AND TGF-BETA BLOCKADE IN PATIENTS WITH HPV+ MALIGNANCIES Read more about COMBINATION PDL1 AND TGF-BETA BLOCKADE IN PATIENTS WITH HPV+ MALIGNANCIES US Patent 11,440,963Filed on 2019-11-11
Combination PDL1 And TGF Beta Blockade In Patients With HPV+ Malignancies Read more about Combination PDL1 And TGF Beta Blockade In Patients With HPV+ Malignancies Japan2019-561944Filed on 2019-11-08
COMBINATION PDL1 AND TGF-BETA BLOCKADE IN PATIENTS WITH HPV+ MALIGNANCIES Read more about COMBINATION PDL1 AND TGF-BETA BLOCKADE IN PATIENTS WITH HPV+ MALIGNANCIES European Patent18729515.9Filed on 2019-12-06
Combination PDL1 And TGF Beta Blockade In Patients With HPV+ Malignancies Read more about Combination PDL1 And TGF Beta Blockade In Patients With HPV+ Malignancies Canada3063087Filed on 2018-05-08
Combination PDL1 And TGF Beta Blockade In Patients With HPV+ Malignancies Read more about Combination PDL1 And TGF Beta Blockade In Patients With HPV+ Malignancies Australia2018266103Filed on 2019-11-08
ANTI-MESOTHELIN POLYPEPTIDES AND PROTEINS Read more about ANTI-MESOTHELIN POLYPEPTIDES AND PROTEINS US Patent 11,390,683Filed on 2019-11-15
TP5, A PEPTIDE INHIBITOR OF ABERRANT AND HYPERACTIVE CDK5/P25 AS TREATMENT FOR CANCER Read more about TP5, A PEPTIDE INHIBITOR OF ABERRANT AND HYPERACTIVE CDK5/P25 AS TREATMENT FOR CANCER Patent Cooperation TreatyPCT/US2019/061251Filed on 2019-11-13